CRNX (CRNX) Stock
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Peer Comparison
About CRNX
CRNX is led by CEO R. Scott Struthers, employs 594 people, headquartered in San Diego, US, publicly traded since 2018.
CRNX stock trades at $84.95 with a market capitalization of $9.00B. The stock is valued at a negative price-to-earnings (P/E) ratio of -16.80, reflecting a net loss over the last twelve months, price-to-book of 7.51, price-to-sales of 213.26. Over the past 52 weeks the stock has ranged between $31.00 and $84.99, and currently trades at or near its 52-week high.
On profitability, CRNX generates a return on equity (ROE) of -44.22% (negative, reflecting a net loss), return on capital employed of -44.21%, an operating margin of -13.08%, a net profit margin of -27.47%.
CRNX by the numbers, 2016–2025
Between 2016 and 2025 CRNX reported revenue of $1.0M rising to $8.0M, a change of +700.0% across 10 years. Compounded, revenue has grown —% a year over five years, 17.0% over three, 700.0% over the last twelve months. Net profit fell to $-465.0M.
Operating margin went from -1026.2% in 2016 to -6714.8% in 2025, a fall of 5688.6 percentage points. The most recent net margin is -27.47%. On a trailing twelve-month basis to Jun '26, revenue is $42.0M and net profit $-502.0M.
Borrowings stand at $49.0M, cash from operations was $-378.0M in the latest year, positive in 0 of the last 10.
Return on equity has averaged -38.7% over five years, and was -46.9% in the most recent year.
The share price itself has compounded at 18.4% a year over five years, 18.5% over three, 10.8% over the last year. Past price movement is history, not a forecast.
Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.
CRNX (CRNX) — frequently asked questions
What is CRNX (CRNX) stock price today?
CRNX (CRNX) is currently trading at $84.95, up 0% today.
What is CRNX P/E ratio?
CRNX's P/E ratio is -16.80. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.
What is CRNX return on equity (ROE)?
CRNX's return on equity (ROE) is -44.22%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.
What is CRNX's market cap?
CRNX has a market capitalization of $9.00B.
Does CRNX pay a dividend?
CRNX is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.
How much debt does CRNX carry?
CRNX has a debt-to-equity ratio of 0.04. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is CRNX's profit margin?
CRNX reports a net profit margin of -27.47% — the share of revenue left after every cost, including tax and interest.
What sector is CRNX in?
CRNX is classified under Healthcare, in the Biotechnology industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is CRNX listed on?
CRNX trades on NASDAQ under the ticker CRNX.
What is CRNX's 52-week range?
Over the last year CRNX has traded between $31.00 and $84.99.
Related Healthcare Stocks
Popular Stocks
Screens CRNX currently matches
On the figures above, CRNX passes the filters for 7 of our ready-made screens, among them Low Debt Stocks, Debt Free Stocks Under $100, Debt Free Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.